Subarachnoidal release of inflammatory cytokines (interleukin (IL)-1â, IL-6, and tumour necrosis factor (TNF)-á) was characterised in 35 patients with sub-arachnoid haemorrhage (SAH) and con-trol subjects and compared with development of complicating haemody-namic abnormalities in basal cerebral arteries and clinical outcome. Serial analysis allowed the observation of a subacute response profile of these key mediators of inflammation in the sub-arachnoidal space. This compartmental-ised inflammatory host response was closely associated in time and extent with development of increased blood flow ve-locities in the basal cerebral vessels as recorded by transcranial Doppler sonog-raphy. Moreover, intrathecal secretion of inflammatory cytokines...
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is still a fatal and morbid disease, although ...
Subarachnoid hemorrhage represents a serious disease with high mortality and morbidity. Two importan...
There is increasing evidence for the role of inflammation in clinical outcome after subarachnoid hem...
BACKGROUND: Inflammatory processes play a key role in the pathophysiology of subarachnoid hemorrhage...
Cerebral vasospasm is a common, formidable, and potentially devastating complication in patients who...
Introduction. Delayed cerebral ischemia (DCI) and cerebral vasospasm (CV) lead to poor outcomes in p...
INTRODUCTION Animal data suggest an association between neuroinflammation and secondary brain inj...
Delayed cerebral vasospasm (DCVS), early brain injury (EBI), and delayed cerebral ischemia (DCI) are...
In den vorgelegten Arbeiten beschreiben wir vasokonstriktive oder inflammatorische Veränderungen nac...
Subarachnoid hemorrhage (SAH) is one of the common clinical neurological emergencies. Its incidence ...
Objective: To perform two scoping systematic reviews of the literature on cytokine measurement in ce...
The delayed ischemic neurologic deficit (DIND) is a common and potentially devastating complication ...
Background: Early cerebral hypoperfusion and ischemia occur after subarachnoid hemorrhage (SAH) and ...
Background and Purpose—Systemic inflammatory response syndrome (SIRS) without infection is a well-kn...
Abstract Background Subarachnoid hemorrhage (SAH) is a fatal disease, with early brain injury (EBI) ...
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is still a fatal and morbid disease, although ...
Subarachnoid hemorrhage represents a serious disease with high mortality and morbidity. Two importan...
There is increasing evidence for the role of inflammation in clinical outcome after subarachnoid hem...
BACKGROUND: Inflammatory processes play a key role in the pathophysiology of subarachnoid hemorrhage...
Cerebral vasospasm is a common, formidable, and potentially devastating complication in patients who...
Introduction. Delayed cerebral ischemia (DCI) and cerebral vasospasm (CV) lead to poor outcomes in p...
INTRODUCTION Animal data suggest an association between neuroinflammation and secondary brain inj...
Delayed cerebral vasospasm (DCVS), early brain injury (EBI), and delayed cerebral ischemia (DCI) are...
In den vorgelegten Arbeiten beschreiben wir vasokonstriktive oder inflammatorische Veränderungen nac...
Subarachnoid hemorrhage (SAH) is one of the common clinical neurological emergencies. Its incidence ...
Objective: To perform two scoping systematic reviews of the literature on cytokine measurement in ce...
The delayed ischemic neurologic deficit (DIND) is a common and potentially devastating complication ...
Background: Early cerebral hypoperfusion and ischemia occur after subarachnoid hemorrhage (SAH) and ...
Background and Purpose—Systemic inflammatory response syndrome (SIRS) without infection is a well-kn...
Abstract Background Subarachnoid hemorrhage (SAH) is a fatal disease, with early brain injury (EBI) ...
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is still a fatal and morbid disease, although ...
Subarachnoid hemorrhage represents a serious disease with high mortality and morbidity. Two importan...
There is increasing evidence for the role of inflammation in clinical outcome after subarachnoid hem...